CN102245583A - 用于治疗血管和代谢疾病的西洛他唑的硝酸酯衍生物 - Google Patents
用于治疗血管和代谢疾病的西洛他唑的硝酸酯衍生物 Download PDFInfo
- Publication number
- CN102245583A CN102245583A CN200980149072XA CN200980149072A CN102245583A CN 102245583 A CN102245583 A CN 102245583A CN 200980149072X A CN200980149072X A CN 200980149072XA CN 200980149072 A CN200980149072 A CN 200980149072A CN 102245583 A CN102245583 A CN 102245583A
- Authority
- CN
- China
- Prior art keywords
- formula
- compound
- compounds
- treatment
- vascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C*N=CC(C(*)C*)OC Chemical compound C*N=CC(C(*)C*)OC 0.000 description 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08170435A EP2194048A1 (en) | 2008-12-02 | 2008-12-02 | Nitrate esters for the treatment of vascular and metabolic diseases |
| EP08170435.5 | 2008-12-02 | ||
| PCT/EP2009/066159 WO2010063724A1 (en) | 2008-12-02 | 2009-12-01 | Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102245583A true CN102245583A (zh) | 2011-11-16 |
Family
ID=40456966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200980149072XA Pending CN102245583A (zh) | 2008-12-02 | 2009-12-01 | 用于治疗血管和代谢疾病的西洛他唑的硝酸酯衍生物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8426597B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2194048A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2012510502A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20110088598A (cg-RX-API-DMAC7.html) |
| CN (1) | CN102245583A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2009324123A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0923300A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2745252A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL213214A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2011005744A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2011126607A (cg-RX-API-DMAC7.html) |
| SG (1) | SG171423A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010063724A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201104011B (cg-RX-API-DMAC7.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114044766A (zh) * | 2021-10-09 | 2022-02-15 | 张北北九食品检验技术有限公司 | 放射性同位素碳-14标记的呋虫胺和中间体及其制备方法和应用 |
| CN120441542A (zh) * | 2025-05-08 | 2025-08-08 | 安徽益普克医药科技发展有限公司 | 一种西洛他唑衍生物及其制备方法与用途 |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR080925A1 (es) | 2010-04-19 | 2012-05-16 | Cardiolynx Ag | Derivados de valsartan que portan donadores de no para el tratamiento de las enfermedades vasculares y metabolicas |
| TW201204355A (en) | 2010-06-02 | 2012-02-01 | Cardiolynx Ag | Nitrate derivatives of pioglitazone |
| PL2888373T3 (pl) | 2012-08-21 | 2018-08-31 | Janssen Pharmaceutica Nv | Przeciwciała dla arypiprazolu i ich zastosowanie |
| PT3305784T (pt) | 2012-08-21 | 2020-10-23 | Janssen Pharmaceutica Nv | Haptenos de quetiapina para utilização em ensaios imunológicos |
| EP2888277A4 (en) | 2012-08-21 | 2016-05-18 | Ortho Clinical Diagnostics Inc | ANTIBODIES AGAINST PALIPERIDONE AND USE THEREOF |
| ES2654413T3 (es) | 2012-08-21 | 2018-02-13 | Janssen Pharmaceutica, N.V. | Anticuerpos a quetiapina y uso de los mismos |
| WO2014031645A1 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc | Antibodies to risperidone haptens and use thereof |
| PL2888286T3 (pl) | 2012-08-21 | 2018-07-31 | Janssen Pharmaceutica Nv | Przeciwciała skierowane przeciwko haptenom kwetiapinowym i ich zastosowanie |
| AU2013305970B2 (en) | 2012-08-21 | 2017-08-17 | Saladax Biomedical Inc. | Antibodies to aripiprazole haptens and use thereof |
| ES2701062T3 (es) | 2012-08-21 | 2019-02-20 | Janssen Pharmaceutica Nv | Haptenos de olanzapina |
| ES2870004T3 (es) | 2012-08-21 | 2021-10-26 | Janssen Pharmaceutica Nv | Anticuerpos contra la risperidona y uso de los mismos |
| ES3057437T3 (en) | 2012-08-21 | 2026-03-02 | Janssen Pharmaceutica Nv | Antibodies to olanzapine haptens and use thereof |
| WO2014031584A1 (en) | 2012-08-21 | 2014-02-27 | Janssen Pharmaceutica Nv | Haptens of aripiprazole and their use in immunoassays |
| JP2015529199A (ja) | 2012-08-21 | 2015-10-05 | オルソ−クリニカル ダイアグノスティクス,インコーポレイティド | パリペリドンハプテンに対する抗体及びその使用 |
| WO2014031662A2 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc | Antibodies to olanzapine and use thereof |
| CA2882560C (en) | 2012-08-21 | 2020-10-27 | Ortho-Clinical Diagnostics, Inc. | Haptens of risperidone and paliperidone for use in immunoassays |
| AU2013305930B2 (en) | 2012-08-21 | 2017-08-24 | Saladax Biomedical Inc. | Haptens of paliperidone |
| CN108368180B (zh) | 2015-12-17 | 2022-07-26 | 詹森药业有限公司 | 喹硫平的抗体及其用途 |
| JP6949025B2 (ja) | 2015-12-17 | 2021-10-13 | ヤンセン ファーマシューティカ エヌ.ベー. | リスペリドンに対する抗体及びその使用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4277479A (en) * | 1978-09-01 | 1981-07-07 | Otsuka Pharmaceutical Co., Ltd. | Tetrazolylalkoxycarbostyril derivatives and pharmaceutical compositions containing them |
| CN1354740A (zh) * | 1999-04-13 | 2002-06-19 | 尼科克斯公司 | 药用化合物 |
| WO2006079610A1 (en) * | 2005-01-31 | 2006-08-03 | Nicox S.A. | Nitrooxy sartan derivatives as angiotensin ii receptor blockers for the treatment of cardiovascular and inflammatory diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0443983B1 (de) | 1990-02-19 | 1996-02-28 | Ciba-Geigy Ag | Acylverbindungen |
| US6148496A (en) | 1999-04-09 | 2000-11-21 | The Procter & Gamble Company | Method for making a seamless apertured metal belt |
| DK1653950T3 (da) | 2003-07-31 | 2008-05-26 | Nicox Sa | Nitrooxyderivater af Losartan, Valsatan, Candesartan, Telmisartan, Eprosartan og Olmesartan som angiotensin II-receptorblokkere til behandling af cardiovaskulære sygdomme |
| EP1922069A2 (en) * | 2005-08-08 | 2008-05-21 | Nitromed, Inc. | Nitric oxide enhancing angiotensin ii antagonist compounds, compositions and methods of use |
-
2008
- 2008-12-02 EP EP08170435A patent/EP2194048A1/en not_active Withdrawn
-
2009
- 2009-12-01 SG SG2011038213A patent/SG171423A1/en unknown
- 2009-12-01 WO PCT/EP2009/066159 patent/WO2010063724A1/en not_active Ceased
- 2009-12-01 BR BRPI0923300A patent/BRPI0923300A2/pt not_active Application Discontinuation
- 2009-12-01 MX MX2011005744A patent/MX2011005744A/es not_active Application Discontinuation
- 2009-12-01 CA CA2745252A patent/CA2745252A1/en not_active Abandoned
- 2009-12-01 CN CN200980149072XA patent/CN102245583A/zh active Pending
- 2009-12-01 US US13/131,722 patent/US8426597B2/en not_active Expired - Fee Related
- 2009-12-01 RU RU2011126607/04A patent/RU2011126607A/ru unknown
- 2009-12-01 KR KR1020117015258A patent/KR20110088598A/ko not_active Withdrawn
- 2009-12-01 JP JP2011538999A patent/JP2012510502A/ja not_active Ceased
- 2009-12-01 AU AU2009324123A patent/AU2009324123A1/en not_active Abandoned
- 2009-12-01 EP EP09793498A patent/EP2367803A1/en not_active Withdrawn
-
2011
- 2011-05-30 IL IL213214A patent/IL213214A0/en unknown
- 2011-05-31 ZA ZA2011/04011A patent/ZA201104011B/en unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4277479A (en) * | 1978-09-01 | 1981-07-07 | Otsuka Pharmaceutical Co., Ltd. | Tetrazolylalkoxycarbostyril derivatives and pharmaceutical compositions containing them |
| CN1354740A (zh) * | 1999-04-13 | 2002-06-19 | 尼科克斯公司 | 药用化合物 |
| WO2006079610A1 (en) * | 2005-01-31 | 2006-08-03 | Nicox S.A. | Nitrooxy sartan derivatives as angiotensin ii receptor blockers for the treatment of cardiovascular and inflammatory diseases |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114044766A (zh) * | 2021-10-09 | 2022-02-15 | 张北北九食品检验技术有限公司 | 放射性同位素碳-14标记的呋虫胺和中间体及其制备方法和应用 |
| CN120441542A (zh) * | 2025-05-08 | 2025-08-08 | 安徽益普克医药科技发展有限公司 | 一种西洛他唑衍生物及其制备方法与用途 |
| CN120441542B (zh) * | 2025-05-08 | 2025-09-30 | 安徽益普克医药科技发展有限公司 | 一种西洛他唑衍生物及其制备方法与用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012510502A (ja) | 2012-05-10 |
| KR20110088598A (ko) | 2011-08-03 |
| AU2009324123A1 (en) | 2011-07-21 |
| BRPI0923300A2 (pt) | 2019-07-16 |
| MX2011005744A (es) | 2011-06-20 |
| ZA201104011B (en) | 2012-02-29 |
| US20110230520A1 (en) | 2011-09-22 |
| EP2194048A1 (en) | 2010-06-09 |
| SG171423A1 (en) | 2011-07-28 |
| IL213214A0 (en) | 2011-07-31 |
| US8426597B2 (en) | 2013-04-23 |
| EP2367803A1 (en) | 2011-09-28 |
| CA2745252A1 (en) | 2010-06-10 |
| WO2010063724A1 (en) | 2010-06-10 |
| RU2011126607A (ru) | 2013-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8426597B2 (en) | Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases | |
| CA2098158A1 (en) | Biphenyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them | |
| WO2003006670A2 (en) | 2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors | |
| JP5604520B2 (ja) | Hdlコレステロール上昇剤としての5−(3,4−ジクロロ−フェニル)−n−(2−ヒドロキシ−シクロヘキシル)−6−(2,2,2−トリフルオロ−エトキシ)−ニコチンアミド及びその塩 | |
| KR19990063850A (ko) | Nmda 길항제로서의 테트라히드로퀴놀린 | |
| JP2003506353A (ja) | 抗凝血物質としてのベンゼンアミン誘導体 | |
| US20100120852A1 (en) | Aroyl-piperidine derivatives and method of treating disorders induced by substance p | |
| JPS63258854A (ja) | カルボキシスチレン誘導体およびそれを有効成分とする薬剤 | |
| JP2015519334A (ja) | 抗血小板薬のプロドラッグ | |
| WO2013167992A1 (en) | Compositions and methods for the treatment of inflammatory disorders | |
| EP2917204B1 (fr) | Derives de 1h-indole-3-carboxamide et leurs utilisation comme antagonistes du p2y12 | |
| CN112010774A (zh) | FXIa凝血因子抑制剂、其药物组合物和用途 | |
| ES2313985T3 (es) | Imidazoles sutituidos como agonistas o antagonistas de histamina h1 y h3. | |
| KR20130115311A (ko) | S1p 수용체의 조절제 | |
| JPH0662547B2 (ja) | グリシン誘導体 | |
| CN114736161A (zh) | 咪唑烷基香草酸醚衍生物及其用途 | |
| WO2021178486A1 (en) | Processes for producing amide compounds, and their crystalline and salt form | |
| EP1098878A1 (fr) | Bispiperidines comme agents antithrombotiques | |
| JP4660197B2 (ja) | 2−(5−クロロチエン−2−イル)−n−{(3s)−1−[(1s)−1−メチル−2−モルホリン−4−イル−2−オキソエチル]−2−オキソピロリジン−3−イル}エテンスルホンアミドの結晶性誘導体 | |
| CN101200443A (zh) | 氮杂环丁酮衍生物、其制备方法及含有它们的药物组合 | |
| JPH07215965A (ja) | インドールスルホンアミド−置換ジヒドロピリジン類 | |
| CN121517394A (zh) | 一种取代的吡啶丙酸衍生物及其用途 | |
| CZ282341B6 (cs) | Nové isobutylsubstituované amidy kyseliny methansulfonyl-chinolylmethoxyfenyl-cykloalkyloctové | |
| WO2023240378A1 (zh) | 咪唑烷基香草酸醚衍生物及其用途 | |
| JPWO2001000588A1 (ja) | ベンズイミダゾール化合物及びこれを含む医薬 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20111116 |